Commonwealth Equity Services
DWTX

Commonwealth Equity Services’s Dogwood Therapeutics DWTX Stock Holding History

Commonwealth Equity Services’s Portfolio DWTX Stock Details DWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-411
Closed -$10K – 4036
2023
Q3 		$10K Sell
411
-204
-33% -$7.09K ﹤0.01% 3780
2023
Q2 		$21K Buy
+615
New +$17.5K ﹤0.01% 3747

Other funds holding DWTX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MCG
McCollum Christoferson Group Amherst, New York $341M AUM 15.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
RFC
Regions Financial Corp Birmingham, Alabama $15.4B AUM 21.7% 1-Year Est. Return

Commonwealth Equity Services's DWTX Position: Q4 2023 in Review

Commonwealth Equity Services sold out of Dogwood Therapeutics (DWTX) in Q4 2023, closing a stake of 411 shares — an estimated $10K sold.

Commonwealth Equity Services first reported a position in DWTX in Q2 2023 and held it in 2 quarters. The position peaked at $21K in Q2 2023. 20 funds tracked by Wall St. Rank hold DWTX as of Q4 2023.

  • Commonwealth Equity Services reported no remaining Dogwood Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Commonwealth Equity Services sold 411 Dogwood Therapeutics shares in Q4 2023, an estimated $10K.
  • Commonwealth Equity Services first reported a position in Dogwood Therapeutics in Q2 2023 and held it in 2 quarters.
  • Commonwealth Equity Services's Dogwood Therapeutics position peaked at $21K in Q2 2023.
  • 20 funds tracked by Wall St. Rank held Dogwood Therapeutics as of Q4 2023.

Based on Commonwealth Equity Services's 13F filing for Q4 2023, filed 6 Feb 2024.